Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Anthony Noto

Deal Dispatch: Del Taco Tanks, Tylenol Maker Aches For Change, Joyebells Burns The Pie

benzinga_deal_dispatch2

New On The Block

  • Tylenol and Listerine maker Kenvue Inc. (NYSE:KVUE) just named board member Kirk Perry as interim CEO, replacing Thibaut Mongon, as part of a strategic review to boost shareholder value. The company, once a part of Johnson & Johnson (NYSE:JNJ) and now a top-five favorite in billionaire Dan Loeb‘s portfolio, aims to simplify operations, possibly via divestitures. In other words, expect Kenvue to conduct the corporate equivalent of mouthwash: rinse and possibly spit out a few underperforming assets.
Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.